LENSAR, Inc. director Elizabeth G. O'Farrell filed a Form 144 notice of proposed sale of securities with the SEC on November 17, 2026, disclosing plans to sell 22,214 shares of common stock acquired through a stock option exercise.
Key Highlights
- Seller and role: Elizabeth G. O'Farrell, a director of LENSAR, Inc., is the person for whose account the securities are to be sold.
- Shares proposed for sale: 22,214 shares of LENSAR common stock, with an aggregate market value of $115,535.01.
- Acquisition method: The shares were acquired via a stock option exercise from the issuer on November 17, 2026, with payment made in cash.
- Approximate sale date: November 17, 2026, through broker Morgan Stanley Smith Barney LLC Executive Financial Services.
- Shares outstanding: 12,294,241 shares of LENSAR common stock were reported as outstanding at the time of the notice.
- Prior sales: The filing reports nothing to disclose regarding securities sold during the past 3 months.
LENSAR Director Files Rule 144 Notice for 22,214-Share Proposed Sale
According to the Form 144 filing, Elizabeth G. O'Farrell, identified as a director of LENSAR, Inc. (NASDAQ:LNSR), provided notice of a proposed sale of 22,214 shares of the company's common stock. The aggregate market value of the shares to be sold was listed as $115,535.01. The filing was submitted with a notice date of November 17, 2026, and identifies the approximate date of sale also as November 17, 2026.
The filing discloses that the shares were acquired on November 17, 2026, through a stock option exercise from the issuer. Payment for the acquisition was made in cash on the same date. The proposed sale is to be executed through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, on the NASDAQ exchange. The filing noted 12,294,241 shares of common stock outstanding at the time of notice.
The filing reports no securities sold by O'Farrell during the past three months. By signing the Form 144, O'Farrell represented, as stated in the filing's attestation language, that she "does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed." LENSAR, Inc. is headquartered at 2800 Discovery Drive, Orlando, Florida 32826.
What Was Disclosed
A Form 144 notice was filed on November 17, 2026, by LENSAR director Elizabeth G. O'Farrell, covering a proposed sale of 22,214 common shares with an aggregate market value of $115,535.01, acquired through a stock option exercise on the same date.



Please wait processing your request...